Literature DB >> 30850822

Cholangiocyte pathobiology.

Jesus M Banales1, Robert C Huebert2, Tom Karlsen3, Mario Strazzabosco4, Nicholas F LaRusso2, Gregory J Gores5.   

Abstract

Cholangiocytes, the epithelial cells lining the intrahepatic and extrahepatic bile ducts, are highly specialized cells residing in a complex anatomic niche where they participate in bile production and homeostasis. Cholangiocytes are damaged in a variety of human diseases termed cholangiopathies, often causing advanced liver failure. The regulation of cholangiocyte transport properties is increasingly understood, as is their anatomical and functional heterogeneity along the biliary tract. Furthermore, cholangiocytes are pivotal in liver regeneration, especially when hepatocyte regeneration is compromised. The role of cholangiocytes in innate and adaptive immune responses, a critical subject relevant to immune-mediated cholangiopathies, is also emerging. Finally, reactive ductular cells are present in many cholestatic and other liver diseases. In chronic disease states, this repair response contributes to liver inflammation, fibrosis and carcinogenesis and is a subject of intense investigation. This Review highlights advances in cholangiocyte research, especially their role in development and liver regeneration, their functional and biochemical heterogeneity, their activation and involvement in inflammation and fibrosis and their engagement with the immune system. We aim to focus further attention on cholangiocyte pathobiology and the search for new disease-modifying therapies targeting the cholangiopathies.

Entities:  

Mesh:

Year:  2019        PMID: 30850822      PMCID: PMC6563606          DOI: 10.1038/s41575-019-0125-y

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  97 in total

1.  Activated cholangiocytes release macrophage-polarizing extracellular vesicles bearing the DAMP S100A11.

Authors:  Tomohiro Katsumi; Maria Eugenia Guicciardi; Adiba Azad; Steven F Bronk; Anuradha Krishnan; Gregory J Gores
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

Review 2.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

Review 3.  Cholangitis Lenta: What Hepatologists Need to Know.

Authors:  Adam L Booth; Shehzad N Merwat; Sheharyar K Merwat; Heather L Stevenson
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-06-30

4.  Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.

Authors:  Vikas Gupta; Ishaan Gupta; Jiwoon Park; Yaron Bram; Robert E Schwartz
Journal:  Gastroenterology       Date:  2020-04-11       Impact factor: 22.682

5.  Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4-/- Mouse.

Authors:  Anuradha Krishnan; Tomohiro Katsumi; Maria E Guicciardi; Adiba I Azad; Nazli B Ozturk; Christy E Trussoni; Gregory J Gores
Journal:  Am J Pathol       Date:  2020-03-30       Impact factor: 4.307

Review 6.  The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis.

Authors:  Maria Eugenia Guicciardi; Christy E Trussoni; Nicholas F LaRusso; Gregory J Gores
Journal:  Hepatology       Date:  2020-02       Impact factor: 17.425

7.  Keratin 19 and mesenchymal markers for evaluation of epithelial-mesenchymal transition and stem cell niche components in primary biliary cholangitis by sequential elution-stripping multiplex immunohistochemistry.

Authors:  John David Paulsen; Briana Zeck; Katherine Sun; Camila Simoes; Neil D Theise; Luis Chiriboga
Journal:  J Histotechnol       Date:  2020-10-01       Impact factor: 0.714

8.  Emerging cell therapy for biliary diseases.

Authors:  Simone N T Kurial; Holger Willenbring
Journal:  Science       Date:  2021-02-19       Impact factor: 47.728

9.  Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-β Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.

Authors:  Sayed Obaidullah Aseem; Nidhi Jalan-Sakrikar; Cheng Chi; Amaia Navarro-Corcuera; Thiago M De Assuncao; Feda H Hamdan; Shiraj Chowdhury; Jesus M Banales; Steven A Johnsen; Vijay H Shah; Robert C Huebert
Journal:  Gastroenterology       Date:  2020-10-12       Impact factor: 22.682

10.  Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.

Authors:  L Valestrand; N L Berntsen; F Zheng; E Schrumpf; S H Hansen; T H Karlsen; R S Blumberg; J R Hov; X Jiang; E Melum
Journal:  Clin Exp Immunol       Date:  2020-11-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.